The 2024 ELN risk stratification was developed with evidence from an exploratory analysis of pooled data from the phase 3 VIALE-A trial and a phase 1 b study of azacitidine plus venetoclax.

"Overall, this study demonstrates the feasibility of applying QPOP as a functional combinatorial precision medicine platform to predict therapeutic sensitivities in AML and provides the basis for ...

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

Pull requests help you collaborate on code with other people. As pull requests are created, they’ll appear here in a searchable and filterable list. To get started, you should create a pull request.

Data elements obtained from the clinical databases for the three recent multinational openlabel clinical trials included patient age, sex, race, AML classification, the duration of first remission ...

Jan. 9, 2025 — An international research team has discovered a new type of skeletal tissue that offers great potential for advancing regenerative medicine and tissue ... Jan. 29, 2025 — Older ...

Today Early in the fall, experts might also see more cases of respiratory syncytial virus, Dr. Geeta Sood, assistant professor of medicine and epidemiologist at Johns Hopkins Bayview Medical Center, ...

This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.

Background: This study aims to identify the hub genes and immune-related pathways in acute myeloid leukemia (AML) to provide new theories for immunotherapy. Methods: We use bioinformatics methods to ...

Johns Hopkins Children’s Center ranks #1 in Maryland, and all 11 specialties are ranked nationally on U.S. News & World Report’s Best Children’s Hospitals list. The Johns Hopkins Hospital is one of ...